Monday, November 7, 2016

UPDATE 2-Valeant agrees to sell Paragon to settle U.S. antitrust charges

WASHINGTON, Nov 7 (Reuters) - Valeant Pharmaceuticals

, which owns eye care products maker Bausch & Lomb, has

agreed to sell Paragon Holdings to settle allegations that its

acquisition of the smaller...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)